Skip to main content
Top
Published in: Pediatric Rheumatology 1/2020

Open Access 01-12-2020 | Juvenile Rheumatoid Arthritis | Research article

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis

Authors: Claire E. H. Barber, Cheryl Barnabe, Susanne Benseler, Ricky Chin, Nicole Johnson, Nadia Luca, Paivi Miettunen, Marinka Twilt, Dwaraka Veeramreddy, Natalie J. Shiff, Heinrike Schmeling

Published in: Pediatric Rheumatology | Issue 1/2020

Login to get access

Abstract

Background

Early diagnosis and treatment of Juvenile Idiopathic Arthritis (JIA) is essential to optimize outcomes. Wait times (WTs) to consultation with a pediatric rheumatologist consultation is a Canadian quality measure, with benchmarks set at 7 days for systemic JIA (sJIA) and 4 weeks for other JIA categories. In this study we assess WTs for JIA at a single academic center and describe factors associated with longer WTs.

Methods

This was a retrospective cohort study of 164 patients enrolled in a pharmacogenetic study in Alberta between 2002 and 2018. Limited chart reviews were conducted to evaluate dates of referral and first rheumatology visit to calculate WTs for receipt of pediatric rheumatology care. Cox proportional hazard models identified factors associated with WTs considering variables at the first pediatric rheumatology visit including: JIA category, age, sex, distance to the pediatric rheumatology clinic, number of active joints, pain and C-reactive protein.

Results

The median age at diagnosis was 8.0 years (interquartile range, IQR 3.5, 12.0) and 46% of patients had oligoarticular JIA. Only 18 patients (11%) were from rural locations. The median WT for all patients met the national benchmark (22 days, IQR, 9, 44) with no statistically significant difference between WTs among JIA categories (p = 0.055). Importantly, the majority of sJIA cases met the 7-day benchmark (67%) with a median WT of 1.5 days. Older age was associated with longer WT (HR 0.94, 95% CI 0.89, 0.98, p = 0.005).

Conclusion

Median benchmarks were met, however delays in older patients highlight the need for monitoring WTs.
Literature
1.
go back to reference O’Donnell S, McRae L, Toews J, Pelletier L, CDDSS Arthritis Working Group. National surveillance of arthritis in Canada, results from the Canadian Chronic Disease Surveillance System (CCDSS). J Rheumatol. 2019;46(7):794. O’Donnell S, McRae L, Toews J, Pelletier L, CDDSS Arthritis Working Group. National surveillance of arthritis in Canada, results from the Canadian Chronic Disease Surveillance System (CCDSS). J Rheumatol. 2019;46(7):794.
2.
go back to reference Public Health Agency of Canada. Candian Chronic Disease Surveillance System (CCDSS). 2018. URL: https://infobase.phac-aspc.gc.ca/CCDSS-SCSMC/data-tool/. Public Health Agency of Canada. Candian Chronic Disease Surveillance System (CCDSS). 2018. URL: https://​infobase.​phac-aspc.​gc.​ca/​CCDSS-SCSMC/​data-tool/​.​
3.
go back to reference Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum. 2009;61:1077–86.CrossRef Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum. 2009;61:1077–86.CrossRef
4.
go back to reference Barber CE, Marshall DA, Mosher DP, Akhavan P, Tucker L, Houghton K, et al. Development of system-level performance measures for evaluation of models of care for inflammatory arthritis in Canada. J Rheumatol. 2016;43:530–40.CrossRef Barber CE, Marshall DA, Mosher DP, Akhavan P, Tucker L, Houghton K, et al. Development of system-level performance measures for evaluation of models of care for inflammatory arthritis in Canada. J Rheumatol. 2016;43:530–40.CrossRef
6.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed
7.
go back to reference Merino R, de Inocencio J, Garcia-Consuegra J. Evaluation of revised international league of associations for rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001). J Rheumatol. 2005;32:559–61.PubMed Merino R, de Inocencio J, Garcia-Consuegra J. Evaluation of revised international league of associations for rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001). J Rheumatol. 2005;32:559–61.PubMed
10.
go back to reference Freychet C, Lambert C, Pereira B, Stephan JL, Echaubard S, Merlin E, et al. Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers. Joint Bone Spine. 2019;86(6):739–45.CrossRef Freychet C, Lambert C, Pereira B, Stephan JL, Echaubard S, Merlin E, et al. Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers. Joint Bone Spine. 2019;86(6):739–45.CrossRef
11.
go back to reference Kavirayani A, Foster HE. Paediatric rheumatology practice in the UK benchmarked against the British Society for paediatric and adolescent rheumatology/arthritis and musculoskeletal alliance standards of care for juvenile idiopathic arthritis. Rheumatology (Oxford). 2013;52(12):2203–7.CrossRef Kavirayani A, Foster HE. Paediatric rheumatology practice in the UK benchmarked against the British Society for paediatric and adolescent rheumatology/arthritis and musculoskeletal alliance standards of care for juvenile idiopathic arthritis. Rheumatology (Oxford). 2013;52(12):2203–7.CrossRef
12.
go back to reference Tzaribachev N, Benseler SM, Tyrrell PN, Meyer A, Kuemmerle-Deschner JB. Predictors of delayed referral to a pediatric rheumatology center. Arthritis Rheum. 2009;61:1367–72.CrossRef Tzaribachev N, Benseler SM, Tyrrell PN, Meyer A, Kuemmerle-Deschner JB. Predictors of delayed referral to a pediatric rheumatology center. Arthritis Rheum. 2009;61:1367–72.CrossRef
13.
go back to reference Shiff NJ, Tucker LB, Guzman J, Oen K, Yeung RS, Duffy CM. Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis. J Rheumatol. 2010;37:2415–21.CrossRef Shiff NJ, Tucker LB, Guzman J, Oen K, Yeung RS, Duffy CM. Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis. J Rheumatol. 2010;37:2415–21.CrossRef
Metadata
Title
Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
Authors
Claire E. H. Barber
Cheryl Barnabe
Susanne Benseler
Ricky Chin
Nicole Johnson
Nadia Luca
Paivi Miettunen
Marinka Twilt
Dwaraka Veeramreddy
Natalie J. Shiff
Heinrike Schmeling
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2020
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-0413-7

Other articles of this Issue 1/2020

Pediatric Rheumatology 1/2020 Go to the issue